(149 days)
Not Found
Not Found
No
The summary describes a traditional surgical laser system and does not mention any AI or ML components or functionalities.
Yes.
The device is used for incision, excision, coagulation, and vaporization of soft tissue, addressing conditions like tumors, lesions, and obstructions, which are therapeutic interventions.
No
The device description clearly states its purpose is for "incision, excision, coagulation and vaporization of soft tissue," which are surgical procedures, not diagnostic ones.
No
The device description explicitly states it is a "surgical laser" and includes a "laser deliver system" with "contact and non-contact devices," indicating it is a hardware-based medical device.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices used to perform tests on samples taken from the human body (like blood, urine, tissue) to provide information about a person's health. They are used outside the body.
- SkinLaser System Function: The description clearly states the SkinLaser System is used for "incision, excision, coagulation and vaporization of soft tissue." This is a surgical procedure performed on the body, not a diagnostic test performed on a sample from the body.
- Intended Use: The intended use describes surgical applications across various specialties, directly interacting with and modifying tissues within the body.
- Device Description: The device description focuses on the laser technology and delivery system for surgical intervention.
The SkinLaser System is a surgical device, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The SkinLaser System is indicated for incision, excision, coagulation and vaporization of soft tissue.
In general surgery, dermatologic and plastic surgery, all soft tissues are included in this indication: skin, subcutis, breast, abdominal and striated and smooth muscle, tendon and fascia, cartilage, mucous membrane, lymph vessels and nodes, and internal organs and glands.
In gynecologic and urologic surgery indications include endoscopic, intraabdominal and externally accessed (free-hand) gynecological and urological tissues, structures, obstructions, strictures, turnors, and other lesions. Only palliative treatment and partial removal of neoplastic tissue should be assumed.
In gastroenterology indications include destruction of polyps, lesions, varices, tumors, and for treatment of hemorrhages.
In pulmonology surgery indications include flexible or a rigid endoscopic and free-hand access and treatment of soft tissue lesions, obstructions, tracheal i stenosis, and turnors.
Product codes
GEX
Device Description
The SkinLaser System is substantially equivalent to continuous wave (CW) and pulsed CW surgical lasers in the wavelength range of 800nm to 1064nm. Such systems have been in surgical use for many years offering broad multi-specialty, multi-procedure applications. The laser deliver system includes both contact and non-contact devices. The function and features of the SkinLaser System is equivalent to or identical to currently marketed devices.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
soft tissue; skin, subcutis, breast, abdominal and striated and smooth muscle, tendon and fascia, cartilage, mucous membrane, lymph vessels and nodes, and internal organs and glands; gynecological and urological tissues, structures, obstructions, strictures, tumors, and other lesions; polyps, lesions, varices, tumors; soft tissue lesions, obstructions, tracheal stenosis, and tumors.
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Not Found
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 878.4810 Laser surgical instrument for use in general and plastic surgery and in dermatology.
(a)
Identification. (1) A carbon dioxide laser for use in general surgery and in dermatology is a laser device intended to cut, destroy, or remove tissue by light energy emitted by carbon dioxide.(2) An argon laser for use in dermatology is a laser device intended to destroy or coagulate tissue by light energy emitted by argon.
(b)
Classification. (1) Class II.(2) Class I for special laser gas mixtures used as a lasing medium for this class of lasers. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 878.9.
0
Page 3 of 7 Jul 7, 1998 11:53:44 a.m.
8 1998 11 11
Image /page/0/Picture/4 description: The image shows a black and white drawing of a design. The design consists of five curved lines that converge and intersect in the middle. Below the curved lines is a thick, horizontal line. The overall design has a symmetrical appearance.
ESEARCH CORPORATION
Fex (215) 885-2788
PREMARKET NOTIFICATION [510(k)] SUMMARY As required by section 807.97(c)
| Submitted by: | Joseph A. Muccini, M.D.
Medical and Regulatory Director |
|----------------------------|------------------------------------------------------------|
| Contact: | Joseph A. Muccini, M.D. or
Terry A. Fuller, Ph.D. |
| Date Prepared: | June 17, 1998 |
| 510(k) Number: | K980501 |
| Trade or Proprietary Name: | SkinLaser |
| Common or Usual Name: | Surgical/Medical Solid State Laser System |
Equivalence:
The SkinLaser System is substantially equivalent to continuous wave (CW) and pulsed CW surgical lasers in the wavelength range of 800nm to 1064nm. Such systems have been in surgical use for many years offering broad multi-specialty, multi-procedure applications. The laser deliver system includes both contact and non-contact devices. The following chart is a partial list of equivalent products currently marketed by other manufacturers.
| Company | Model / Power | Wavelength,
Aiming beam
wavelength | Other |
|----------------------------------|----------------------------------|------------------------------------------|--------------------------------------------------------------------------|
| Fuller Research
Corporation | SkinLaser ST-25 25W
laser | 800-980nm,
655nm aiming
beam | Proprietary fiber
connector, CW & Pulsed,
internal cooling system, |
| Surgimedics, Diomed,
Ltd. | Diomed 15W, 25W and
60W laser | 780 - 830nm,
650nm aiming
beam | SMA fiber connector, CW
& pulsed, internal cooling
system |
| Applied Optronics
Corporation | AOC-25, 25W laser | 980nm,
655nm aiming
beam | SMA fiber connector, CW
& Pulsed, internal cooling
system |
| Indigo Medical, Inc. | Indigo 830, 20W laser | 830nm,
670nm aiming
beam | SMA fiber connector, CW
& Pulsed, internal cooling
system |
| Endocare Medical | DioLase 60, 60W laser | 950-1010nm,
red aiming
beam | SMA fiber connector, CW
& Pulsed, internal cooling
system |
The function and features of the SkinLaser System is equivalent to or identical to currently marketed devices. Thus, the SkinLaser System is not a "new" device and can be marketed for the Indications for Use as systems currently marked.
1
PREMARKET NOTIFICATION [510(k)] SUMMARY (Continued)
Indications for Use include:
The SkinLaser System is indicated for incision, excision, coagulation and vaporization of soft tissue.
In general surgery, dermatologic and plastic surgery, all soft tissues are included in this indication: skin, subcutis, breast, abdominal and striated and smooth muscle, tendon and fascia, cartilage, mucous membrane, lymph vessels and nodes, and internal organs and glands.
In gynecologic and urologic surgery indications include endoscopic, intraabdominal and externally accessed (free-hand) gynecological and urological tissues, structures, obstructions, strictures, tumors, and other lesions. Only palliative treatment and partial removal of neoplastic tissue should be assumed.
In gastroenterology indications include destruction of polyps, lesions, varices, tumors, and for treatment of hemorrhages.
In pulmonology surgery indications include flexible or a rigid endoscopic and free-hand access and treatment of soft tissue lesions, obstructions, tracheal stenosis, and tumors.
2
Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized depiction of an eagle or bird-like figure. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the emblem.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
8 1998 . Il Jl
Terry A. Fuller, Ph.D. · President Fuller Research Corporation 944 Mogan Road Rydal, Pennsylvania 19046
Re: K980501 Trade Name: Skin Laser System Regulatory Class: II Product Code: GEX Dated: May 27, 1998 Received: May 29, 1998
Dear Dr. Fuller:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations. Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (OS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
3
Page 2 - Dr. Terry Fuller
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4595. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".
Sincerely yours,
ia M. Witten, Ph.D., M.D. Cel Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
510(k) Number: Device Name:
K980501 SkinLaser System Page 1 of 1
Indications for Use:
The SkinLaser System is indicated for incision, excision, coagulation and vaporization of soft tissue.
In general surgery, dermatologic and plastic surgery, all soft tissues are included in this indication: skin, subcutis, breast, abdominal and striated and smooth muscle, tendon and fascia, cartilage, mucous membrane, lymph vessels and nodes, and internal organs and glands.
In gynecologic and urologic surgery indications include endoscopic, intraabdominal and externally accessed (free-hand) gynecological and urological tissues, structures, obstructions, strictures, turnors, and other lesions. Only palliative treatment and partial removal of neoplastic tissue should be assumed.
In gastroenterology indications include destruction of polyps, lesions, varices, tumors, and for treatment of hemorrhages.
In pulmonology surgery indications include flexible or a rigid endoscopic and free-hand access and treatment of soft tissue lesions, obstructions, tracheal i stenosis, and turnors.
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
|--|--|
| (Division Sign-Off) | |
|---|---|
| Division of General Restorative Devices/ | |
| 510(k) Number | 9800501 |
Prescription Use (Per 21 CFR 801.109)
OR
Over-The-Counter Use_
(Optional Format 1-2-96)